Article Details
Retrieved on: 2022-01-26 19:39:53
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Morgan Stanley reissued an "underweight" rating and set a GBX 400 ($5.40) target price on shares of Synthomer in a research note on Wednesday.
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here